MENU

AOMC-JMS 2024 AOMC-JMS 2024

Program

Schedule

As of Wednesday, September 11, 2024

Program

Educational Programme Opening Remarks

Sep 12(Thu.)10:25-10:30Room2

Prof. Ichizo Nishino(National Center of Neurology and Psychiatry, Japan)

Educational Programme 1

Sep 12(Thu.)10:30-12:00Room2

Chair
Dr. Sara Khan(Aga Khan University Hospital, Pakistan)
Dr. Kazuma Sugie(Nara Medical University, Japan)
EP1-1How to examine infants suspected to have neuromuscular disorders
Dr. Wen-Chen Liang(Kaohsiung Medical University Hospital, Taiwan)
EP1-2Characteristics, natural history and management of LAMA2-related dystrophies: A multi-cohort study from the Asian-Oceanian Network
Prof. Hui Xiong(Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, China)
EP1-3Examination of an adult patient with Muscle and Neuromuscular junctions disorders
Prof. Atchayaram Nalini(National Institute of Mental Health and Neurosciences, India)

Educational Programme 2

Sep 12(Thu.)13:10-14:40Room2

Chair
Dr. Chongbo Zhao(Huashan Hospital, Fudan University, China)
Dr. Rajesh Benny(Fortis Hospital, India)
EP2-1Making Sense of the Clinical spectrum of Limb Girdle Muscular Dystrophies
Prof. Satish V. Khadilkar(Bombay Hospital Institute of Medical Sciences, India)
EP2-2Congenital myasthenic syndromes: Review of 38 causal genes
Prof. Kinji Ohno(Nagoya University Graduate School of Medicine, Japan)
EP2-3The expanding genetic landscape of hereditary rhabdomyolysis: what clinicians need to know
Prof. Teerin Liewluck(Mayo Clinic-Rochester, USA)

Educational Programme 3

Sep 12(Thu.)14:50-16:20Room2

Chair
Dr. Katsuhisa Ogata(National Hospital Organization Higashisaitama Hospital, Japan)
Dr. Anna Cho(Seoul National University Bundang Hospital, Korea)
EP3-1Rehabilitation for progressive neuromuscular disorders: focus on Duchenne muscular dystrophy
Dr. Kimiko Inoue(National Hospital Organization Osaka Toneyama Medical Center, Japan)
EP3-2Pulmonary rehabilitation and management of dysphagia in patients with neuromuscular disorders
Dr. Yuka Ishikawa(National Hospital Organization Hokkaido Medical Center, Japan)
EP3-3Pathophysiology and management of cardiomyopathy associated with neuromuscular disease
Dr. Atsuhito Takeda(Hokkaido University Graduate School of Medicine, Japan)

Educational Programme 4

WMS Collaborate session

Sep 12(Thu.)16:30-18:00Room2

Chair
Dr. Wen-Chen Liang(Kaohsiung Medical University Hospital, Taiwan)
A/Prof. Gina Ravenscroft(University of Western Australia, Australia)
EP4-1Muscle Imaging
Prof. Jordi Alberto Diaz-Manera(Newcastle University, UK)
EP4-2Differential diagnosis of IBM
Prof. Werner Stenzel(Charite University Hospital, Germany)
EP4-3Genetic diagnosis of muscle diseases: from gene-by-gene testing through next generation sequencing toward genomic medicine
Prof. Alessandra Ferlini(University of Ferrara, Italy)

Opening Ceremony

Sep 13(Fri.)8:30-9:00Room1

Chair
Prof. Ichizo Nishino(National Center of Neurology and Psychiatry, Japan)

Keynote Lecture 1

Sep 13(Fri.)9:10-10:40Room1

Chair
Prof. Yoshihide Sunada(Kawasaki Medical School, Japan)
Prof. Ichizo Nishino(National Center of Neurology and Psychiatry, Japan)
K-1Emerging Therapies for Thymidine Phosphorylase and Thymidine Kinase 2 Deficiencies
Prof. Michio Hirano(Columbia University Irving Medical Center, USA)

Keynote Lecture 2

Sep 13(Fri.)9:10-10:40Room1

Chair
Satish V. Khadilkar(Bombay Hospital Institute of Medical Sciences)
Dr. Kazuma Sugie(Nara Medical University, Japan)
K-2
Dr. Yoshitsugu Aoki(National Center of Neurology and Psychiatry, Japan)

Symposium 1 [AOMC-TREAT-NMD collaboration]

Clinical trials in NMD- Challenges we face

Sep 13(Fri.)10:50-12:20Room1

Chair
Prof. Dae-Seong Kim(Pusan National University Yangsan Hospital, Korea)
Prof. Yukiko K. Hayashi(Tokyo Medical University, Japan)
S1-1The importance of involving patients in therapy development
Lessons learned from Duchenne exon skipping
Prof. Annemieke Aartsma-Rus(Leiden University Medical Center, Netherlands)
S1-2Therapeutic approaches in Duchenne muscular dystrophy: fall, rise, and challenges
Prof. Alessandra Ferlini(University of Ferrara, Italy)
S1-3Clinical Trial Readiness in Myotonic Dystrophy
Prof. Masanori Takahashi(Osaka University, Japan)

Symposium 2

Link between Research, Clinical trials, and Patient registries

Sep 13(Fri.)13:30-15:00Room1

Chair
Prof. Sophelia Hoi-Shan Chan(The University of Hong Kong, Hong Kong SAR, China)
Dr. Yuko Shimizu-Motohashi(National Center of Neurology and Psychiatry, Japan)
S2-1Current status in South Korea: From patients registry to Clinical trials
Prof. Jong-Hee Chae(Seoul National University College of Medicine, Korea)
S2-2Interconnection between Research, Clinical Trials, and Neuromuscular Patient Registries in Thailand
Prof. Oranee Sanmaneechai(Mahidol University, Thailand)
S2-3Advancements in FSHD Research: Insights from the Hong Kong FSHD Patient Registry and Innovative AI Applications
Prof. Sophelia Hoi-Shan Chan(The University of Hong Kong, Hong Kong SAR, China)
S2-4Congenital muscular dystrophies and myopathies: Current status in Japan
Dr. Yuko Shimizu-Motohashi(National Center of Neurology and Psychiatry, Japan)

Symposium 3

Myositis Update

Sep 13(Fri.)15:10-16:40Room1

Chair
Dr. Akinori Uruha(Tokyo Metropolitan Neurological Hospital, Japan)
Dr. Jantima Tanboon(Mahidol University, Thailand)
S3-1Myositis classification and pathology: an update (Part 1)
Prof. Werner Stenzel(Charite University Hospital, Germany)
S3-2Myositis classification and pathology: an update (Part 2) Dermatomyositis, Antisynthetase syndrome, and a few others
Dr. Jantima Tanboon(Mahidol University, Thailand)
S3-3Update on Muscle Imaging in Idiopathic Inflammatory Myopathy (IIM)
Prof. Tahseen Mozaffer(University of California, Irvine, USA)
S3-4Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR T-cell therapy
Prof. Wei Wang(Huazhong University of Science and Technology, China)
S3-5Unlocking the Mystery: The Pathogenic Role of Anti-cN1A Antibodies in Inclusion Body Myositis
Prof. Satoshi Yamashita(International University of Health and Welfare Narita Hospital, Japan)
S3-6Autoimmunity against melanoma differentiation-associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice
Prof. Naoko Okiyama(Tokyo Medical and Dental University, Japan)

Symposium 4

Current Status of the Neuromuscular Field in New Member and Expected-to-be New Member Countries

Sep 13(Fri.)16:50-18:20Room1

Chair
Prof. Umapathi Thirugnanam(National Neuroscience Institute, Singapore)
Dr. Ohnmar(Yangon General Hospital/University of Medicine 1, Myanmar)
S4-1An Overview of Myology in Vietnam: From AOMC 2017 to the Present
Dr. Si Tri Le(University Medical Center of Hochiminh, Vietnam)
S4-2Challenges and lessons learnt in setting up clinical, eletrodiagnostic and pathologic services for neuromuscular diseases in Iraq
Prof. Abdulnasir Hassin Am(Alhadi Neuromuscular Diseases Center, Iraq)
S4-3Management of neuromuscular diseases in Kazakhstan
Dr. Altynshash Jaxybayeva(Astana Medical University, Kazakhstan)
S4-4Emerging from the ashes and founding myology services in Sri Lanka
Dr. Sanjaya Fernando(Ministry of Health Sri Lanka)
S4-5Neurological Care in Afghanistan with 40 million population faces a rising neurological disease burden, including encephalitis, meningitis, malaria, measles and stroke. Neurological care is limited, with only two neurologists trained at The Aga Khan University. Challenges include poor awareness, inadequate training, and financial constraints. FMIC is working to improve services and establish a residency program.
Dr. Esmatullah Hamed(French Medical University for Mothers and Children, Afghanistan)

Symposium 5

Recent advances in sarcopenia and frailty studies

Sep 13(Fri.)16:50-18:20Room2

Chair
Prof. Akiyoshi Uezumi(Kyushu University, Japan)
Dr. Satoru Noguchi(National Instituteof Neuroscience, National Center of Neurology and Psychiatry, Japan)
S5-1Research update of sarcopenia in Asia
Prof. Dr. Hidenori Arai(National Center for Geriatrics and Gerontology, Japan)
S5-2Athlete Giftedness and Genetics
Prof. Hiroshi Asahara(Tokyo Medical and Dental University, Japan)
S5-3The diverse functions of NAD-dependent lysine deacylase SIRT7 in the musculoskeletal systems.
Prof. Tatsuya Yoshizawa(Kyoto Prefectural University of Medicine, Japan)
S5-4The Androgen-Androgen Receptor Signaling in skeletal muscle: Insights into the Mechanisms of Sarcopenia Development and Potential Aging Regulation
Dr. Tatsuya Hosoi(The University of Tokyo, Japan)

Symposium 6

Muscle atrophy and hypertrophy

Sep 14(Sat.)9:00-10:30Room1

Chair
Dr. Masaki Inada(Tokyo University of Agriculture and Technology, Japan)
Dr. Naoki Suzuki(Tohoku University, Japan)
S6-1Elucidation of Skeletal Muscle Regulation Mechanisms Using Mouse Space Experiments
Prof. Satoru Takahashi(University of Tsukuba, Japan)
S6-2Differential gene responses for slow-twitch and fast-twitch muscles in muscular atrophy and hypertrophy.
Prof. Dr. Masaki Inada(Tokyo University of Agriculture and Technology, Japan)
S6-3MicroRNA199 is involved in muscle differentiation and muscle hypertrophy
Prof. Dr. Hirohiko Hohjoh(Graduate School of Medicine, Juntendo University, Japan)
S6-4Diverse roles of cellular senescence in skeletal muscle inflammation and regeneration
Dr. Yuki Saito(Sapporo Medical Universiry, Japan)

Symposium 7

Muscle stem cells in Development, Regeneration and Homeostatis

Sep 14(Sat.)10:40-12:10Room1

Chair
Dr. Shinichiro Hayashi(National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan)
Prof. So-ichiro Fukada(Graduate School of Pharmaceutical Sciences, Osaka University, Japan)
S7-1Molecular mechanisms regulating behaviors of muscle satellite cells in response to intrinsic and extrinsic factors
Prof. So-ichiro Fukada(Graduate School of Pharmaceutical Sciences, Osaka University, Japan)
S7-2Role of mechanosensitive ion channels during myofiber regeneration
Prof. Yuji Hara(School of Pharamaceutical Sciences, University of Shizuoka, Japan)
S7-3Functional heterogeneity in the activated satellite cell population
Prof. Yusuke Ono(Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University, Japan)
S7-4Development of Cell Therapy for DMD by iPSC-derived Muscle Stem Cell (iMuSC)
Assoc. prof. Hidetoshi Sakurai(Center for iPS Research and Application (CiRA), Kytoto University, Japan)

Symposium 8

Muscle mechanosensing and Physical activities

Sep 14(Sat.)13:30-15:00Room1

Chair
Dr. Takashi Yamada(Sapporo Medical University, Japan)
Dr. Norio Motohashi(National Center of Neurology and Psychiatry, Japan)
S8-1Age-related dysfunction of NAD+ metabolism and Ca2+ signaling in skeletal muscle as a cause of anabolic resistance
Dr. Naoki Ito(National Center for Geriatrics and Gerontology, Japan)
S8-2in vivo intracellular calcium ion dynamics regulating exercise-induced muscle damage: Spatio-temporal characteristics and its underlying mechanism
Dr. Ayaka Tabuchi(The University of Electro-Communications, Japan)
S8-3Intramuscular Regulation of Post-Exercise Glucose Clearance
Dr. Kohei Kido(National Institute of Advanced Industrial Science and Technology, Japan)
S8-4Deciphering the mechanisms underlying the positive effects of exercise on organismal homeostasis from mechanobiological perspectives, thereby developing novel therapeutic/preventative strategies for a variety of diseases and disorders
Dr. Yasuhiro Sawada(National Rehabilitation Center for Persons with Disabilities, Japan)

Symposium 9

Treatable Neuro Muscular Disorders

Sep 14(Sat.)13:30-15:00Room2

Chair
Prof. Khean-Jin Goh(University of Malaya, Malaysia)
Dr. Sara Khan(Aga Khan University Hospital, Pakistan)
S9-1State of the art in lipid storage myopathy
Prof. Chuanzhu Yan(Qilu Hospital, Shandong University, China)
S9-2Current landscape of sporadic late-onset nemaline myopathy
Dr. Akinori Uruha(Tokyo Metropolitan Neurological Hospital, Japan)
S9-3Gene-Targeted Therapy for Duchenne Muscular Dystrophy: Clinical Development Update
Dr. Hirofumi Komaki(National Center of Neurology and Psychiatry, Japan)
S9-4Challenges and Opportunities in the Treatment of Spinal Muscular Atrophy
Prof. Yuh-Jyh Jong(Kaohsiung Medical University Hospital, Taiwan)

Symposium 10

Perspectives on skeletal muscle and organ interactions in homeostasis and disease

Sep 14(Sat.)15:10-16:40Room1

Chair
Dr. Keisuke Hitachi(Fujita Health University, Japan)
Dr. Tomoya Uchimura(Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan)
S10-1The role of muscle-derived extracellular vesicles in aging.
Dr. Naoomi Tominaga(Yamaguchi University, Japan)
S10-2Crosstalk between skeletal muscle and bone
Dr. Naoyuki Kawao(Kindai University Faculty of Medicine, Japan)
S10-3The role of exercise-induced myokines in cardiovascular homeostasis
Dr. Koji Ohashi(Nagoya University, Japan)
S10-4Skeletal muscle atrophy-induced cognitive dysfunction: its mechanism and protective strategy
Prof. Chihiro Tohda(University of Toyama, Japan)

Symposium 11

Other myopathies

Sep 14(Sat.)15:10-16:40Room2

Chair
Prof. Raymond L. Rosales(University of Santo Tomas, Philippines)
Dr. Charungthai Dejthevaporn(Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand)
S11-1Anncaliia algerae infection: potentially fatal, unclear epidemiology.
Dr. Matthew Watts(Ministry of Health & University of Sydney, Australia)
S11-2Electrodiagnostic and myopathologic correlation in critical illness myopathy.
Prof. Teerin Liewluck(Mayo Clinic-Rochester, USA)
S11-3Muscle Chaperonopathies: From Clinical Presentation to Molecular Mechanisms
Dr. Michio Inoue(Washington University School of Medicine, USA)
S11-4Ten years of disease gene discovery and diagnostics in neurogenetic diseases
Assoc. Prof. Gina Ravenscroft(University of Western Australia, Australia)
S11-5VCP Myopathy
Prof. Jordi Alberto Diaz-Manera(Newcastle University, UK)

Symposium 12

Advancing Next-Generation Therapeutic Modalities for Muscular Disorders

Sep 15(Sun.)9:00-10:30Room1

Chair
Dr. Yoshitsugu Aoki(National Center of Neurology and Psychiatry, Japan)
Dr. Masayuki Nakamori(Yamaguchi University, Japan)
S12-1Development of immune tolerance-inducing gene therapy using mesenchymal cells
Prof. Takashi Okada(The Institute of Medical Science, The University of Tokyo, Japan)
S12-2Pentatricopeptide repeat protein targeting CUG repeat RNA ameliorates RNA toxicity in myotonic dystrophy type 1
Dr. Masayuki Nakamori(Yamaguchi University, Japan)
S12-3CDP-ribitol prodrug treatment ameliorates ISPD-deficient muscular dystrophy
Prof. Motoi Kanagawa(Ehime University, Japan)
S12-4Exon skipping therapy using a novel chimeric RNA fused with 4.5SH
Prof. Shinichi Nakagawa(Hokkaido University, Japan)

Symposium 13

New technologies and models to facilitate muscle research

Sep 15(Sun.)10:40-12:10Room1

Chair
Dr. Tsukasa Tominari(National Center of Neurology and Psychiatry, Japan)
Dr. Ai Shima(The University of Tokyo, Japan)
S13-1Skeletal muscle delivery tools of CRISPR-Cas genome editing
Dr. Akitsu Hotta(Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan)
S13-2Investigating and Developing Treatments for Triadopathies Using Zebrafish Pre-Clinical Models
Dr. Yukari Endo(Juntendo University, Japan)
S13-3Production of human muscle tissues based on cell sheet-based tissue engineering
Dr. Hironobu Takahashi(Tokyo Women’s Medical University, Japan)
S13-4Disease modeling of Duchenne muscular dystrophy for the functional analyses by muscle training using patient-derived iPSC in vitro.
Dr. Tomoya Uchimura(Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan)

JSNP Joint Symposium

Pathomechanism of OPDM and related disorders

Sep 14(Sat.)16:50-18:50Room1

Chair
Dr. Takashi Kurashige(NHO Kure Medical Center and Chugoku Cancer Center, Japan)
Dr. Jun Sone(Aichi Medical University, Japan)
Noncoding repeat expansions in OPDM and related disorders and their mechanisms
Prof. Hiroyuki Ishiura(Okayama University, Japan)
RAN translation and RNA foci: Causing differentiation of phenotype
Dr. Takashi Kurashige(NHO Kure Medical Center and Chugoku Cancer Center, Japan)
RNA G-quadruplexes cause neuronal dysfunction in trinucleotide CGG repeat diseases
Prof. Norifumi Shioda(Institute of Molecular Embryology and Genetics (IMEG), Kumamoto University, Japan)
Muscle pathology of OPDM – how to differentiate from OPMD
Dr. Masashi Ogasawara(Showa General Hospital, Japan)
Neuronal intranuclear inclusion disease
Dr. Jun Sone(Aichi Medical University, Japan)
Neuropathology of OPDM
Dr. Rie Saito(Brain Research Institute, Niigata University, Japan)

AOMC Young Investigator Award Session

Sep 14(Sat.)9:00-10:30Room2

Chair
Shahriar Nafissi(Department of Neurology Tehran University of Medical Sciences)
Yuh-Jyh Jong(Department of Pediatrics and Laboratory Medicine Kaohsiung Medical University Hospital)
AY-1Visualization of degenerative processes of the myofibers on muscle pathology in OPDM based on single nucleus RNA-seq data
Ai Yamanaka(Department of Neuromuscular Research, National Center of Neurology and Psychiatry, Tokyo, Japan)
AY-2Detection of STR expansions on a neuromuscular gene panel using STRipy improves diagnostic rate of ataxia
Chiara Lai Folland(Centre for Medical Research, University of Western Australia, Harry Perkins Institute of Medical Research, Perth, Western Australia, Australia)
AY-3Characterizing the Cell-Cell Interaction in Inclusion Body Myositis
Francia Victoria De Los Reyes(Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan)
AY-44qA D4Z4 methylation test as a valuable complement for differential diagnosis in patients with FSHD-like phenotype
Xingyu Xia(Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China)
AY-5Identification of key gene functions impaired in dystrophinopathy by transcriptomic analysis of patient-derived iPSC-cardiomyocytes
Jeffrey Lui(Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, HKSAR)

JMS Young Investigator Award Session

Sep 14(Sat.)10:40-12:30Room2

Chair
Yuh-Jyh Jong(Department of Pediatrics and Laboratory Medicine Kaohsiung Medical University Hospital)
JY-1Serglycin promotes skeletal myogenesis through EZH2 degradation in satellite cells
Katsuhiko Kunitake
JY-2Macrophage HGF-denitration activity: a key to youthful muscle regeneration
Alaa Elgaabari(Department of Animal and Marine Bioresource Sciences, Graduate School of Agriculture, Kyushu University, Fukuoka, Japan)
JY-3Generation of an FSHD1 mouse model carrying FSHD1-derived chromosome 4q35 using mouse artificial chromosome
Yosuke Hiramuki(Department of Chromosome Biomedical Engineering, School of Life Science, Faculty of Medicine, Tottori University)
JY-4The role of muscle glucocorticoid receptor signaling in accelerating obesity, glucose intolerance, and aging-related metabolic changes
Hiroki Yamazaki(Division of Endocrinology and Metabolism, Department of Internal Medicine, Teikyo University School of Medicine)
JY-5Modeling cell type specific and sporadic DUX4 gene expression in FSHD
Mitsuru Sasaki-Honda(CiRA, Kyoto University, Japan)
JY-6Establishment of Cell Transplantation Therapy Aimed at Ameliorating Ullrich Congenital Muscular Dystrophy~Exploration of Cell Sources for Transplantation~
Megumi Yokomizo (Goto)(Center for iPS Cell Research and Application (CiRA), Kyoto University)

JMS Student Award Poster Presentation Session

Sep 13(Fri.)18:30-20:30Poster Room

Chair
Masayuki Nakamori(Department of Neurology Yamaguchi University)
Motoi Kanagawa(Department of Cell Biology and Molecular Medicine, Ehime University)
Akiyoshi Uezumi(Division of cell heterogeneity of Medical Institute of Bioregulation Kyushu University)
So-ichiro Fukada(Laboratory of Stem Cell Regeneration and Adaptation Graduate School of Pharmaceutical Sciences, Osaka University)
JSA-1LSMEM2, localized at the neuromuscular junction, modulatesMitochondrial integration in skeletal muscles
Eman Elrefaei(Osaka University, Medical Biochemistry department, faculty of medicine)
JSA-2Satellite cells are not indispensable for repair following exercise-induced muscle damage
Nao Tokuda(Graduate School of Health Sciences, Sapporo Medical University, Sapporo, Japan)
JSA-3Reactive oxygen species related DNA damage induced cellular senescence in myoblasts
Daichi Arai(Cooperative Major of Advanced Health Science,Tokyo University of Agriculture and Technology)
JSA-4Overexpression of PGC-1α prevents eccentric contraction-induced muscle damage in a utrophin-independent manner
Azuma Naito(Graduate School of Health Sciences, Sapporo Medical University, Sapporo, Japan)
JSA-5Isometric interval training with high- but not low-intensity contractions improves fatigue resistance in dystrophin deficient muscle
Nao Yamauchi(Graduate School of Health Sciences, Sapporo Medical University, Sapporo, Japan)
JSA-6Next-generation cell and gene therapy
Edvinas Cerniauskas(CiRA, Kyoto University)
JSA-7Inactivation of Aconitase2 under simulated microgravity and analysis of skeletal muscle-specific Aco2-deficient mice
Minori Suzuki(Department of Nutritional Physiology, The Medical Nutrition, Graduate School of Tokushima University)
JSA-8Elucidation of the mechanism by which training improves the engraftment efficiency of transplanted cells in Duchenne muscular dystrophy
Mayuho Miki(Department of Clinical application, Center for iPS cell Research and Application, Kyoto University)
JSA-9BMP signaling controls skeletal muscle cell maturation
Takumi Makino(Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo)
JSA-10A mechanistic analysis of epigenetic disruption in Facioscapulohumeral muscular dystrophy
Takumi Kishimoto(Department of Clinical application, Center for iPSCs Research and Application (CiRA), Kyoto University)
JSA-11RNA-based CRISPRoff silencing to target DUX4 in Facioscapulohumeral muscular dystrophy
Junjie He(Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan)
JSA-12Reduced expression of Dok-7 and agrin due to mechanical unloading induces acetylcholine receptor degeneration in type 1 myofibers in mice
Tatsuhiro Yamaguchi(The University of Tokyo)
JSA-13Elucidating the role of Oncostatin M signaling in myoblast proliferation and muscle physiology in wild-type and SOD1G93A mice
Chang Chen(Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry)
JSA-14Development of in vitro neuromuscular junction model through direct reprogramming of human urine-derived cells from Amyotrophic lateral sclerosis
Kazuki Okoshi(Department of Molecular Therapy, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP) , Japan)

JMS Student Award Session

Sep 15(Sun.)8:00-8:50Room1

Chair
Hiroshi Sakai(Ehime University)
Mikako Ito(Nagoya University Graduate School of Medicine)

※Only the Student Award candidates selected for the second round will present their research (an oral presentation) here.

Clinical Pathological Conference

Sep 15(Sun.)9:30-12:10Room2

Chair
Ichizo Nishino(National Center of Neurology and Psychiatry, Japan)
Kum Thong Wong(University of Malaya, Malaysia)

Award and Closing Ceremony

Sep 15(Sun.)13:20-14:20Room1

Luncheon Seminar 1

Emerging Science in SMA Treatment for Better Outcomes

Sep 12(Thu.)12:10-13:00Room2
Sponsored by Biogen Japan Ltd.

Chair
Dr. Hirofumi Komaki(National Center of Neurology and Psychiatry, Japan)
LS1-1Clinical Experience of Spinal Muscular Atrophy in the Era of Newborn Screening and Treatment
Dr. Yin-Hsiu Chien(National Taiwan University Hospital, Taiwan)
LS1-2Neurofeedback rehabilitation using robot-suits hybrid assistive limb (HAL)
Dr. Takashi Nakajima(NHO Niigata National Hospital, Japan)

Luncheon Seminar 2

Sep 13(Fri.)12:30-13:20Room1
Sponsored by Alexion Pharma G.K Medical Affairs Division

Chair
Prof. Ichizo Nishino(Department of Neuromuscular Research National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan)
LS2Long-Term Treatment Strategies for Myasthenia Gravis
Dr. Kimitoshi Kimura(Department of Neurology, Graduate school of Medicine and Faculty of Medicine, Kyoto University, Japan)

Luncheon Seminar 3

Generalized Myasthenia Gravis Seminar -Entering a New Stage -

Sep 13(Fri.)12:30-13:20Room2
Sponsored by UCB Japan Co. Ltd.

Chair
Dr. Kazuma Sugie(Professor & Chairman of Department of Neurology Nara Medical University, Japan)
LS3The Forefront of gMG Treatment - Positioning of Subcutaneous Injections -
Dr. Hiroyuki Murai(Professor and Chairman of Department of Neurology, International University of Health and Welfare, Japan)

Sponsored Symposium

Multidisciplinary Approach to Muscular Dystrophy Management

Sep 13(Fri.)15:30-16:40Room2
Sponsored by Pfizer Japan Inc.

Chair
Dr. Hirofumi Komaki(Director, Translational Medical Center, National Center of Neurology and Psychiatry, Japan)
SS1Motor Function Assessment in the Treatment of Muscular Dystrophy
Dr. Keiko Ishigaki(Associate Professor, Department of Pediatrics, Tokyo Women's Medical University School of Medicine, Japan)
SS2Cardiac Management of the Patient with Muscular Dystrophy
Dr. Mi Kyoung Song(Associate Professor, Pediatrics, Seoul National University Hospital, Korea)
SS3Usefulness of Japanese National Registry of Muscular Dystrophy (Remudy)
Dr. Harumasa Nakamura(Director, Department of Clinical Research Support, National Center of Neurology and Psychiatry, Japan)
SS4Multidisciplinary Approach to Management of Muscular Dystrophy Treatment in Korea
Dr. Jong-Hee Chae(Professor, Pediatrics, Seoul National University Hospital, Korea)

Morning Seminar

Exploring Neu-REFIX Beta Glucans: Mechanisms and Effects in Reducing Muscle Fibrosis and Fatigue.

Sep 14(Sat.)8:00-8:50Room1
Sponsored by GN Corporation Co Ltd, Japan

Chair
Prof. Masaru Iwasaki(Vice-President, University of Yamanashi, Kofu, Japan)
MSOral administration of Neu-REFIX Beta 1,3-1,6 Glucans reduces skeletal muscle fibrosis and fatigue in dystrophic mice.
Dr. Yoshitsugu Aoki(Head, Department of Molecular Therapy, National Center for Neurology and Psychiatry (NCNP), Tokyo, Japan)

Luncheon Seminar 4

The diagnosis and treatment of treatable childhood-onset neuromuscular diseases.

Sep 14(Sat.)12:35-13:25Room1
Sponsored by CHUGAI PHARMACEUTICAL CO., LTD.

Chair
Dr. Hiroyuki Awano(Research Initiative Center, Organization for Research Initiative and Promotion, Tottori University, Japan)
LS4The diagnosis and treatment of treatable childhood-onset neuromuscular diseases.
Dr. Keiko Ishigaki(Associate Professor, Department of Pediatrics Tokyo Women's Medical University, School of Medicine, Japan)

Luncheon Seminar 5

Treatment Strategies for Generalized Myasthenia Gravis

Sep 15(Sun.)12:20-13:10Room1
Sponsored by argenx Japan K.K.

Chair
Prof. Masanori Takahashi(Lab of Clinical Neurophysiology, Dept. Clinical Laboratory and Biomedical Sciences, Osaka University Graduate School of Medicine, Japan)
LS5-1Clinical impact of efgartigimod, the first approved anti-neonatal Fc receptor inhibitor for MG in Japan.
Dr. Shigeaki Suzuki(Department of Neurology, Keio University School of Medicine, Japan)
LS5-2Efgartigimod therapy in patients with myasthenia gravis of working age: challenges encountered by patients with MG at work and when caring for children.
Dr. Akitoshi Takeda(Department of Neurology, Osaka Metropolitan University, Japan)

Luncheon Seminar 6

Updates on GNE Myopathy Treatment in Japan

Sep 15(Sun.)12:20-13:10Room2
Sponsored by Nobelpharma Co., Ltd

Chair
Prof. Ichizo Nishino(National Center of Neurology and Psychiatry, Japan)
LS6-1Recent Insights into GNE Myopathy: Genotype-Phenotype Correlations, Disease Progression, and Therapeutic Approaches Beyond Sialic Acid Supplementation
Dr. Wakako Yoshioka(National Center of Neurology and Psychiatry, Japan)
LS6-2A New Era in the Treatment of Distal Myopathy: Expectations and Future Prospects for Aceneuramic acid
Dr. Naoki Suzuki(Tohoku University Graduate School of Medicine, Japan)

※Please provide your assigned Abstract Code when you apply for the Poster Printing Service.

TOP